Management Change/Compensation Form 8 K

Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

Nemaura Medical Inc. (the "Company") has taken measures to reduce overhead and enhance operating efficiency by outsourcing the bulk of its operations. While the majority of manufacturing activities were already outsourced from the outset, the Company is now seeking to outsource its remaining operations, specifically sensor production, to a contract manufacturing organization. In connection therewith, on May 1, 2024, the Company issued termination notices to staff, including Arash Ghadar, the Company's Chief Operating Officer. Consistent with the terms of Mr. Ghadar's employment agreement, the effective date of Mr. Ghadar's termination was November 1, 2024.

On September 20, 2024, Arash Ghadar requested early termination of his employment agreement and the Company agreed. Accordingly, Mr. Ghadar resigned his position as the Company's Chief Operating Officer on September 20, 2024.

In addition, on September 21, 2024, Asim Butt resigned his position as a member of the Company's Board of Directors. Mr. Butt's resignation was not because of a disagreement with the Company on a matter relating to the Company's operations, policies or practices.